| 标题 |
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Simron Singh; Daniel Halperin; S. Myrehaug; Ken Herrmann; Marianne Pavel,; et al 出版日期:2024-06-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)